2021, Number 2
<< Back Next >>
Rev Mex Patol Clin Med Lab 2021; 68 (2)
Evaluation of a rapid test versus a chemiluminescent microparticle immunoassay for the detection of antibodies against SARS-CoV-2
Lara-Sanjuan F, Parra-Ortega I, Sánchez PS, Alcaraz RD, Rodríguez MF, López-Martínez B
Language: Spanish
References: 18
Page: 45-50
PDF size: 274.51 Kb.
ABSTRACT
Introduction: Serology allows us to quickly detect SARS-CoV-2 positive patients, isolate them and cut the epidemiological chain; Therefore, lateral flow assays have been designed to identify IgG/IgM antibodies in serum. In Mexico, COFEPRIS approved several rapid tests, used for diagnosis of COVID-19.
Material and methods: The Vazyme 2019-nCoV IgG/IgM kit, was evaluated sensitivity and specificity compared to the results of two automated immunoassays, SARS-CoV-2 IgG/IgM (ARCHITECT, Abbott), using serum from 75 patients diagnosed with SARS-CoV-2 and 25 negative to SARS-CoV-2.
Results: Sensitivity and specificity were obtained individually (100 and 52% IgG Vazyme, 15.2% and 100% IgM Vazyme) and globally 100%, 60%, respectively.
Conclusion: We show that the Vazyme rapid test performs underperforming compared to the ARCHITECT test, so its use for COVID diagnosis is limited its use for the diagnosis of COVID-19.
REFERENCES
Palacios CM, Santos E, Velázquez CMA, León JM. COVID-19, a worldwide public health emergency, Revista Clínica Española. 2021; 221 (1): 55-61. doi: org/10.1016/j.rce.2020.03.001.
Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A Brief Overview. 2020; 131 (1): 93-96. doi: 10.1213/ANE.0000000000004845.
WHO. WHO coronavirus disease (COVID-19) dashboard 2021 [citado 02/03/2021]. Available in: https://covid19.who.int/
InDRE. Listado de Pruebas Moleculares Útiles Por RT-PCR, evaluadas para el diagnóstico de SARS-CoV-2 (Última Actualización 17 De Febrero De 2021). Disponible en: https://www.gob.mx/salud/documentos/listado-de-pruebas-moleculares-por-rt-pcr-monoplexado-sars-cov-2?state=published.
Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020; 92: 1518-1524. Available in: https://doi.org/10.1002/jmv.25727
Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V et al. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol. 2020; 129: 104511. Available in: https://doi.org/10.1016/j.jcv.2020.104511
Blacka MA, Shen G, Feng X, Garcia BWF, Feng Y, Vasudevaraja V. Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples. J Immunol Methods. 2021; 489: 112909. Available in: https://doi.org/10.1016/j.jim.2020.112909
Pflüger LS, Bannasch JH, Brehm TT, Pfefferle S, Hoffmann A, Norz D et al. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients. J Clin Virol. 2020; 130: 104549. https://doi.org/10.1016/j.jcv.2020.104549
Naaber P, Hunt K, Pesukova J, Haljasmagi L, Rumm P, Peterson P et al. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLOS ONE. 2020; 15 (10): e0237548. Available in: https://doi.org/10.1371/journal.pone.0237548
Van Tol S, Mogling R, Li W, Godeke GJ, Swart A, Bergmans B et al. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach. Emerg Microbes Infect. 2020; 9 (1): 1965-1973. doi: 10.1080/22221751.2020.1813636.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. medRxiv: the preprint server for health sciences. 2020; 2020.03.17.20037713. Available in: https://doi.org/10.1101/2020.03.17.20037713
Malagón-Rojas J, Gómez-Rendón C, Parra EL, Almentero J, Palma R, López R et al. SARS-CoV-2 y RT-PCR en pacientes asintomáticos: resultados de una cohorte de trabajadores del Aeropuerto Internacional El Dorado de Bogotá, 2020. Biomédica. 2020; 40 (Supl. 2): 166-172. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/5802
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323 (14): 1406-1407. https://doi.org/10.1001/jama.2020.2565
Krygier R, Stepien PM, Zarebska-Michaluk D. Rapid serological tests for SARS-CoV-2 IgG/IgM- not worth attention? Int J Occup Med Environ Health. 2021; 34 (2): 203-209. Available in: https://doi.org/10.13075/ijomeh.1896.01756
Meng QB, Peng JJ, Wei X, Yang JY, Li PC, Qu ZW et al. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid. World J Clin Cases. 2020; 8 (19): 4360-4369. Available in: https://doi.org/10.12998/wjcc.v8.i19.4360
Chan CW, Shahul S, Coleman C, Tesic V, Parker K, Yeo KJ. Evaluation of the truvian easy check COVID-19 IgM/IgG lateral flow device for rapid anti-SARS-CoV-2 antibody detection. Am J Clin Pathol. 2021; 155 (2): 286-295. Available in: https://doi.org/10.1093/ajcp/aqaa221
Vizcaíno-Salazar GJ. Importancia del cálculo de la sensibilidad, la especificidad y otros parámetros estadísticos en el uso de las pruebas de diagnóstico clínico y de laboratorio. Med Lab. 2017; 23 (7-8): 365-386. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/34
Xie X, Nielsen MC, Muruato AE, Fontes-Garfias CR, Ren P. Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test. Diagn Microbiol Infect Dis. 2021; 99 (2): 115248. Available in: https://doi.org/10.1016/j.diagmicrobio.2020.115248